Evidence map›Paper›PMID 35865536›Full record

ArticleFrontiers in immunology2022

Grass Carp Mex3A Promotes Ubiquitination and Degradation of RIG-I to Inhibit Innate Immune Response.

Zeyin Jiang, Zhichao Sun, Jihuan Hu, Dongming Li, Xiaowen Xu, Meifeng Li, Zhiqing Feng, Shanshan Zeng, Huiling Mao, Chengyu Hu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zeyin JiangSchool of Life Science, Key Laboratory of Aquatic Resources and Utilization of Jiangxi Province, Nanchang University, Nanchang, China.
Zhichao SunSchool of Life Science, Key Laboratory of Aquatic Resources and Utilization of Jiangxi Province, Nanchang University, Nanchang, China.
Jihuan HuSchool of Life Science, Key Laboratory of Aquatic Resources and Utilization of Jiangxi Province, Nanchang University, Nanchang, China.
Dongming LiSchool of Basic Medical Sciences, Fuzhou Medical University, Fuzhou, China.
Xiaowen XuSchool of Life Science, Key Laboratory of Aquatic Resources and Utilization of Jiangxi Province, Nanchang University, Nanchang, China.
Meifeng LiSchool of Life Science, Key Laboratory of Aquatic Resources and Utilization of Jiangxi Province, Nanchang University, Nanchang, China.
Zhiqing FengSchool of Life Science, Key Laboratory of Aquatic Resources and Utilization of Jiangxi Province, Nanchang University, Nanchang, China.
Shanshan ZengSchool of Life Science, Key Laboratory of Aquatic Resources and Utilization of Jiangxi Province, Nanchang University, Nanchang, China.
Huiling MaoSchool of Life Science, Key Laboratory of Aquatic Resources and Utilization of Jiangxi Province, Nanchang University, Nanchang, China.
Chengyu HuSchool of Life Science, Key Laboratory of Aquatic Resources and Utilization of Jiangxi Province, Nanchang University, Nanchang, China.
Nanchang University · CNFujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As one of the Mex3 family members, Mex3A is crucial in cell proliferation, migration, and apoptosis in mammals. In this study, a novel gene homologous to mammalian Mex3A (named

Indexed as

CarpsAnimalsImmunity, InnateMammalsPoly I-CSignal TransductionUbiquitinationUbiquitin-Protein LigasesPoly I-CUbiquitin-Protein LigasesfishMex3Anegative regulatorRIG-Iubiquitination

Identifiers

PMID35865536
PMCPMC9295999
OpenAlexW4283806446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.